AF
BIOA

Allworth Financial’s BioAge Labs BIOA Stock Holding History

Allworth Financial’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99 Sell
4
-7
-64% -$126 ﹤0.01% 5024
2026
Q1 		$193 Buy
+11
New +$212 ﹤0.01% 4930

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Allworth Financial's BIOA Position: Q2 2026 in Review

Allworth Financial reduced its BioAge Labs (BIOA) stake by 64% in Q2 2026, selling an estimated $126 and leaving 4 shares worth $99. The position accounts for ﹤0.01% of the portfolio, ranked #5024.

Allworth Financial first reported a position in BIOA in Q1 2026 and has held it in 2 quarters since. The position peaked at $193 in Q1 2026. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Allworth Financial held 4 shares of BioAge Labs worth $99 as of Q2 2026.
  • Allworth Financial sold 7 BioAge Labs shares in Q2 2026, an estimated $126.
  • BioAge Labs made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #5024 holding.
  • Allworth Financial first reported a position in BioAge Labs in Q1 2026 and has held it in 2 quarters since.
  • Allworth Financial's BioAge Labs position peaked at $193 in Q1 2026.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.